1. Home
  2. GHG vs RZLT Comparison

GHG vs RZLT Comparison

Compare GHG & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GHG

GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

HOLD

Current Price

$1.76

Market Cap

205.1M

ML Signal

HOLD

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

HOLD

Current Price

$2.19

Market Cap

187.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GHG
RZLT
Founded
2004
2010
Country
China
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.1M
187.3M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
GHG
RZLT
Price
$1.76
$2.19
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$12.33
AVG Volume (30 Days)
22.4K
14.8M
Earning Date
12-23-2025
02-11-2026
Dividend Yield
5.62%
N/A
EPS Growth
N/A
N/A
EPS
0.25
N/A
Revenue
$166,761,937.00
N/A
Revenue This Year
$19.02
N/A
Revenue Next Year
$8.26
N/A
P/E Ratio
$7.12
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.66
$1.07
52 Week High
$3.25
$11.46

Technical Indicators

Market Signals
Indicator
GHG
RZLT
Relative Strength Index (RSI) 43.22 29.86
Support Level $1.66 $1.78
Resistance Level $1.99 $2.82
Average True Range (ATR) 0.08 0.42
MACD 0.01 -0.05
Stochastic Oscillator 30.30 11.44

Price Performance

Historical Comparison
GHG
RZLT

About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Share on Social Networks: